The NLRP3 inflammasome, being a valuable diagnostic biomarker, has been previously characterized in various mental health conditions, encompassing depression, Alzheimer’s disease, anxiety disorders, cognitive impairments, post-traumatic stress disorder, and autism spectrum disorders (Çelik et al., 2022). This evidence concerns the gene NLRP3 and anxiety disorder.